MRSH Maintained by Wells Fargo -- Price Target Raised to $197
Wells Fargo maintained an Equal-Weight rating on Marsh (MRSH) and raised its price target to $197 from $183. GuruFocus values MRSH at $255.35, suggesting a 26.7% undervaluation. The company has a GF Score of 84/100, with strong profitability and growth but low momentum. Insiders have sold $8.21M in shares over the past three months.
How this was made
The 30-second read
Why it matters
The target increase may attract value-oriented investors, but insider sell‑off and weak momentum temper expectations.
Market read
A modest analyst upgrade with limited immediate trading impact; primarily of interest to value investors tracking Marsh.
What to watch
Potential macro headwinds for insurance underwriting not reflected in the target.
Background
Wells Fargo maintains an Equal-Weight rating on Marsh while lifting its price target, reflecting cautious optimism.
Ticker impact
Wells Fargo raised its price target for Marsh to $197 from $183, a new analyst action disclosed today.
likely slight upward pressure as investors price in higher target
Target raise signals improved outlook, but equal-weight rating and low momentum suggest limited immediate move.
Market effects
May reinforce positive sentiment for the insurance brokerage sector, but limited impact.
U.S. market focus; no broader regional effect.
Minimal global relevance beyond Marsh's shareholders.
Counterpoint
Insider selling and low momentum could signal overvaluation despite the target raise.
Key entities
- analystWells Fargo
Equity research firm providing the rating and price target.
- companyMarsh & McLennan (MRSH)
Insurance brokerage and risk management firm.
